Orchestra BioMed Holdings, Inc. Investing Cash Flow
Orchestra BioMed Holdings, Inc. (OBIO) reported Investing Cash Flow of -$12.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$23.31M, a 242.51% decline year-over-year.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $10.32M, a 20.62% decline year-over-year.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$17.71M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$38.58M, a 7027.11% decline year-over-year.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$26.94M, a 305.83% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $13.09M, a 22.48% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $10.69M.
- Orchestra BioMed Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$64.12M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 4 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 7 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$23.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$12.99M 10-Q · filed 2026-08-10 | -$30.70M derived: sum of 3 quarters · filed 2026-08-10 | -$69.29M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $10.32M 10-Q · filed 2026-05-12 | -$7.39M derived: sum of 2 quarters · filed 2026-05-12 | -$45.98M derived: sum of 3 quarters · filed 2026-05-12 | -$29.62M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$17.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$56.30M derived: sum of 2 quarters · filed 2026-03-12 | -$39.94M derived: sum of 3 quarters · filed 2026-08-10 | -$26.94M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$38.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$22.23M derived: sum of 2 quarters · filed 2026-08-10 | -$9.23M 10-Q · filed 2025-11-10 | -$12.98M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $16.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $29.36M 10-Q · filed 2026-08-10 | $25.60M derived: sum of 3 quarters · filed 2026-08-10 | $26.16M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $13.00M 10-Q · filed 2026-05-12 | $9.25M derived: sum of 2 quarters · filed 2026-05-12 | $9.80M derived: sum of 3 quarters · filed 2026-05-12 | $20.23M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$3.20M derived: sum of 2 quarters · filed 2026-03-12 | $7.23M derived: sum of 3 quarters · filed 2026-03-12 | $13.09M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $557.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $10.98M derived: sum of 2 quarters · filed 2025-11-10 | $16.84M 10-Q · filed 2025-11-10 | $49.99M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $10.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $16.29M 10-Q · filed 2025-08-12 | $49.44M derived: sum of 3 quarters · filed 2025-08-12 | $62.38M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $5.86M 10-Q · filed 2025-05-12 | $39.01M derived: sum of 2 quarters · filed 2025-05-12 | $51.96M derived: sum of 3 quarters · filed 2025-05-12 | $60.08M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $33.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $46.10M derived: sum of 2 quarters · filed 2025-03-31 | $54.22M derived: sum of 3 quarters · filed 2025-03-31 | $10.69M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $12.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $21.07M derived: sum of 2 quarters · filed 2024-11-12 | -$22.46M 10-Q · filed 2024-11-12 | -$85.84M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $8.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$35.41M 10-Q · filed 2024-08-12 | -$98.79M derived: sum of 3 quarters · filed 2024-08-12 | -$99.01M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$43.53M 10-Q · filed 2024-05-13 | -$106.91M derived: sum of 2 quarters · filed 2024-05-13 | -$107.13M derived: sum of 3 quarters · filed 2024-05-13 | -$107.60M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$63.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$63.60M derived: sum of 2 quarters · filed 2024-03-27 | -$64.08M derived: sum of 3 quarters · filed 2024-03-27 | -$64.12M 10-K · filed 2024-03-27 | $92.59M 10-K · filed 2023-01-25 | |||
| 2022-09-30 | -$224.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$698.00K derived: sum of 2 quarters · filed 2023-11-13 | -$745.00K 10-Q · filed 2023-11-13 | $92.59M 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$474.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$521.00K 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$47.00K 10-Q · filed 2023-05-12 | |||||||
| 2020-12-31 | -$160.00M 10-K/A · filed 2022-03-31 | |||||||
| 2020-09-30 | -$160.00M 10-Q/A · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |